Cryo-Cell International Net Income

Cryo-Cell International (CCEL) currently reports a net income of $-2.8M as of August 2026. That compares with $400K in the prior-year period — down 805.3% year over year. That is below the Healthcare sector average of $1.5T. Use the charts on this page to explore Cryo-Cell International's net income history and peer comparisons.

Cryo-Cell International's net income decreased from $400K to $-2.8M — a 805.3% year-over-year decrease (period ending August 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cryo-Cell International's net income of $-2.8M is lower than the Healthcare sector average of $1.5T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Cryo-Cell International reported $-2.8M in net income as of August 2026. That compares with $400K in the prior-year period — down 805.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-2.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $1.5T. From there, open related valuation or income-statement pages for Cryo-Cell International, and consider following CCEL for alerts when major investors trade the stock.